Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Elaine Tan Su Yin"'
Autor:
Fatima Mohammed, Umniha Siddig Ahmed Elgailani, Sondos Yassir Ibrahim Ali, Razan Faisal Abdullah Mohamed, Elaine Tan Su Yin, Martha L. Bravo-Vasquez
Publikováno v:
Conflict and Health, Vol 18, Iss 1, Pp 1-4 (2024)
Abstract The ongoing conflict in Gaza has led to severe destruction of the health system and eventually its collapse. Moreover, multiple attacks on health workers were reported which led to obstacles in service delivery. The conflict has led to furth
Externí odkaz:
https://doaj.org/article/6e929ec6408d4489bfe81c479b02d499
Autor:
Adriana Viola Miranda, Katherine Feng, Ave Põld, Muhammed Yaseen Tagari, Sherly Meilianti, Shahd Sharief, Elaine Tan Su Yin, Rahmot Afolabi
Publikováno v:
Public Health Challenges, Vol 2, Iss 2, Pp n/a-n/a (2023)
Abstract The multisectoral nature of emerging global health threats, such as climate change, antimicrobial resistance, and food security, requires holistic solutions. Planetary health, which encompasses the relationship between human systems– polit
Externí odkaz:
https://doaj.org/article/d0349dcd3c5c4a2e85b275c782d0c28d
Autor:
Yafei Zhang, Guangfa Wang, Xin Zhao, Yongxian Hu, Elaine Tan Su Yin, Donghe Chen, Huatao Wang, Kui Zhao
Publikováno v:
BMC Medical Imaging, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background It has been reported the prognostic value of MTV in predicting the disease prognosis of peripheral T-cell lymphoma (PTCL) through pre-treatment PET/CT imaging. However, these are limited data on pretreatment evaluation and prognos
Externí odkaz:
https://doaj.org/article/46b1023cf18f4168aa33a82b4d935110
Publikováno v:
ImmunoMedicine, Vol 2, Iss 1, Pp n/a-n/a (2022)
Abstract Chimeric antigen receptors (CAR) T‐cell therapy is one of the most effective treatments in curing hematologic malignancies. Besides the four CD19 CAR T‐cells therapy recently approved by the US Food and Drug Administration (FDA), CD20 CA
Externí odkaz:
https://doaj.org/article/32939fc747924d238e8275448fc36a1f
Autor:
Yue Huang, Qin Yu, Elaine Tan Su Yin, Guoqing Wei, Wenjun Wu, Alex H. Chang, He Huang, Yongxian Hu
Publikováno v:
ImmunoMedicine, Vol 2, Iss 1, Pp n/a-n/a (2022)
Abstract The genetically engineered chimeric antigen receptor T cell (CAR‐T) therapy has shown remarkable clinical efficacy in the treatment of hematological malignancies. Nonetheless, it is difficult to harvest adequate autologous T cells to manuf
Externí odkaz:
https://doaj.org/article/1198a788ca4241e8ac5cf5fec36ba4b2
Publikováno v:
ImmunoMedicine, Vol 2, Iss 1, Pp n/a-n/a (2022)
Abstract Increasing use of chimeric antigen receptor‐T (CAR‐T) cell therapy has significantly improved the survival of hematologic malignancy patients, but CAR‐T cell treatment is also associated with increased risk of infection. Hence, underst
Externí odkaz:
https://doaj.org/article/2f25f26672464fe38a644e32a4c148bb
Autor:
Houli Zhao, Jieping Wei, Guoqing Wei, Yi Luo, Jimin Shi, Qu Cui, Mingfeng Zhao, Aibin Liang, Qing Zhang, Jianmin Yang, Xin Li, Jing Chen, Xianmin Song, Hongmei Jing, Yuhua Li, Siguo Hao, Wenjun Wu, Yamin Tan, Jian Yu, Yanmin Zhao, Xiaoyu Lai, Elaine Tan Su Yin, Yunxiong Wei, Ping Li, Jing Huang, Tao Wang, Didier Blaise, Lei Xiao, Alex H. Chang, Arnon Nagler, Mohamad Mohty, He Huang, Yongxian Hu
Publikováno v:
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-13 (2020)
Abstract Background Consolidative allogeneic hematopoietic stem cell transplantation is a controversial option for patients with relapsed/refractory acute lymphoblastic leukemia after chimeric antigen receptor T cell (CAR-T) therapy. We performed a m
Externí odkaz:
https://doaj.org/article/0d9754ba37f949e9a37c2ca215e508a1
Autor:
Yiyun Wang, Linqin Wang, Yifan Zeng, Ruimin Hong, Cheng Zu, Elaine Tan Su Yin, Houli Zhao, Guoqing Wei, Li Yang, Aiyun Jin, Yongxian Hu, He Huang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Multiple myeloma (MM) with central nervous system (CNS) involvement is rare with only 1% incidence. So far, there is no standard or effective treatment for CNS MM, and the expected survival time is fewer than 6 months. Here, we report a case of MM wi
Externí odkaz:
https://doaj.org/article/cbd20a4390f643e0b766499414165902
Autor:
Ruimin Hong, Elaine Tan Su Yin, Linqin Wang, Xin Zhao, Linghui Zhou, Guangfa Wang, Mingming Zhang, Houli Zhao, Guoqing Wei, Yiyun Wang, Wenjun Wu, Yafei Zhang, Fang Ni, Yongxian Hu, He Huang, Kui Zhao
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Chimeric antigen receptor (CAR) T-cell therapy has exhibited promising clinical outcomes in treating relapsed/refractory (R/R) B-cell hematologic malignancies. Current studies have shown a close correlation between baseline tumor burden and therapeut
Externí odkaz:
https://doaj.org/article/60b213ea9f6b4e5aa3aa19508ffc66c9
Publikováno v:
Clinical Hematology International, Vol 2, Iss 4 (2020)
Externí odkaz:
https://doaj.org/article/9ac6ef4b345c4428b87e02c8c95ee044